The Latest in Psoriasis

Guselkumab’s efficacy, safety confirmed in patients with psoriatic arthritis and prior TNFi exposure

December 2, 2021

Does the use of frankincense make sense in dermatology?

November 9, 2021

Certain DMTs in MS linked to more psoriasis

November 1, 2021

Psoriasis

Better COVID-19 outcomes confirmed in TNF inhibitor users

October 22, 2021

Study of biologics’ impact on psoriasis-to-PsA transition contradicts previous findings

October 13, 2021

Nonsteroidal topical found effective for psoriasis in 52-week study

October 4, 2021

Psoriasis

First-in-class TYK inhibitor shows durable effect for psoriasis

October 1, 2021

NIAMS director reflects on her mentors, spotlights research projects underway

October 1, 2021

Acceptance of biosimilars grows but greater use may hinge on switching, interchangeability studies

September 30, 2021

More severe psoriasis linked to an increased risk of PsA

September 28, 2021

European agency recommends two new adalimumab biosimilars

September 20, 2021

Medicare patients’ cost burden for specialty psoriasis, PsA drugs remains high

September 15, 2021

Ask about itch and joint pain in pediatric psoriasis patients, expert advises

September 2, 2021

Biologic benefit in psoriasis might extend to arthritis prevention

August 30, 2021

Bimekizumab approved in Europe for psoriasis treatment

August 25, 2021